You are here: Home » PTI Stories » National » News
Business Standard

Granules gets EIR from USFDA for Telangana facility

Press Trust of India  |  New Delhi 

Pharma firm today said the US health regulator has issued Establishment Inspection Report (EIR) after of its facility.

"The Food and Drug Administration (USFDA) has issued Establishment Inspection Report (EIR) for the company's located at Hyderabad, Telangana, India," Granules said in a BSE filing.

The company said this facility was inspected by the USFDA in March 2018 and there was one observation during the inspection. Granules said it has responded to the observation within the stipulated time frame.

manufactures (APIs) and (PFIs), the company added.

The USFDA issues an to the establishment that is the subject of an FDA or FDA-contracted inspection when the agency decides to close the inspection.

The company's shares were trading 0.16 per cent higher at Rs 94.80 on BSE.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, May 16 2018. 10:45 IST